# A multi-mics exploration of programmed cell death in non-obstructive azoospermia: identifying TLR4 as a central regulator and therapeutic target

**Authors:** Qi Yu, Qingtao Yang, Shiwang Yuan, Yili Zhao, Wei Li, Jun Qiao, Fa Sun, Tao Li

PMC · DOI: 10.3389/fcell.2026.1742608 · Frontiers in Cell and Developmental Biology · 2026-02-06

## TL;DR

This study explores how programmed cell death contributes to male infertility and identifies TLR4 as a key gene involved in non-obstructive azoospermia.

## Contribution

The study identifies TLR4 as a central regulator and therapeutic target for non-obstructive azoospermia.

## Key findings

- 150 PCD-related genes were found to be dysregulated in non-obstructive azoospermia.
- TLR4 was identified as a causally linked hub gene in the development of non-obstructive azoospermia.
- Environmental pollutants and natural products that target TLR4 were identified through database screening and molecular docking.

## Abstract

Male infertility (MI) is a globally recognized public health challenge, affecting approximately 18% of men of reproductive age worldwide. Non-obstructive azoospermia (NOA) is a major cause of NOA and is associated with dysregulated programmed cell death (PCD). However, the precise role and mechanisms of PCD in the pathogenesis of NOA remain poorly understood.

In this study, target genes associated with both PCD and NOA were retrieved from multiple public databases. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analyses were then performed to explore underlying mechanisms. Subsequently, protein-protein interaction (PPI) network analysis identified hub genes within the network. Mendelian randomization (MR) analysis was further conducted to establish a causal relationship between key genes and NOA susceptibility. Thereafter, in vitro cell and molecular biology experiments validated the impact of the pathogenic gene on LPS-induced GC-1 spg (ts) cell injury. Finally, we queried the Comparative Toxicogenomics Database (CTD) to identify environmental exposures and natural bioactive products targeting the pathogenic gene, followed by molecular docking analysis to confirm their interactions.

Our analysis identified 150 PCD-related genes that were dysregulated in NOA. GO and KEGG enrichment analyses indicated that these targets primarily regulate cell death, senescence, inflammation, oxidative stress, and various biosynthetic processes. PPI analysis identified 10 hub genes: HIF1A, TLR4, MDM2, GPX4, SNCA, MTOR, CSNK2A2, ATG5, CTSS, and PIK3CA. Subsequent MR analysis established TLR4 as being causally associated with an increased risk of NOA. In vitro experiments confirmed the involvement of TLR4 in LPS-induced damage to GC-1 spg (ts) cells. Finally, CTD database screening and molecular docking analyses identified 8 common environmental pollutants and 9 natural active products that potentially target TLR4, thereby influencing the initiation and progression of NOA.

This study advances the understanding of PCD in the pathogenesis of NOA. It identifies and underscores the critical role of the core PCD-related gene TLR4 in NOA development, highlighting the necessity for strategies aimed at mitigating its negative impact on fertility.

## Linked entities

- **Genes:** TLR4 (toll like receptor 4) [NCBI Gene 7099], HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091], MDM2 (MDM2 proto-oncogene) [NCBI Gene 4193], GPX4 (glutathione peroxidase 4) [NCBI Gene 2879], SNCA (synuclein alpha) [NCBI Gene 6622], MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475], CSNK2A2 (casein kinase 2 alpha 2) [NCBI Gene 1459], ATG5 (autophagy related 5) [NCBI Gene 9474], CTSS (cathepsin S) [NCBI Gene 1520], PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) [NCBI Gene 5290]
- **Diseases:** male infertility (MONDO:0005372)

## Full-text entities

- **Genes:** SNCA (synuclein alpha) [NCBI Gene 6622] {aka NACP, PARK1, PARK4, PD1}, BLNK (B cell linker) [NCBI Gene 29760] {aka AGM4, BASH, BLNK-S, LY57, SLP-65, SLP65}, Snca (synuclein, alpha) [NCBI Gene 20617] {aka NACP, alpha-Syn, alphaSYN}, TLR4 (toll like receptor 4) [NCBI Gene 7099] {aka ARMD10, CD284, TLR-4, TOLL}, Csnk2a2 (casein kinase 2, alpha prime polypeptide) [NCBI Gene 13000] {aka 1110035J23Rik, CK2}, AKT1 (AKT serine/threonine kinase 1) [NCBI Gene 207] {aka AKT, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA}, Atg5 (autophagy related 5) [NCBI Gene 11793] {aka 2010107M05Rik, 3110067M24Rik, Apg5l, Atg5l, Paddy}, Mdm2 (MDM2 proto-oncogene) [NCBI Gene 17246] {aka 1700007J15Rik, Mdm-2}, MDM2 (MDM2 proto-oncogene) [NCBI Gene 4193] {aka ACTFS, HDMX, LSKB, hdm2}, Tlr4 (toll-like receptor 4) [NCBI Gene 21898] {aka Lps, Ly87, Ran/M1, Rasl2-8}, CTSS (cathepsin S) [NCBI Gene 1520], Mtor (mechanistic target of rapamycin kinase) [NCBI Gene 56717] {aka 2610315D21Rik, FRAP, FRAP2, Frap1, RAFT1, RAPT1}, Ctss (cathepsin S) [NCBI Gene 13040] {aka Cats}, GAPDH (glyceraldehyde-3-phosphate dehydrogenase) [NCBI Gene 2597] {aka G3PD, GAPD, HEL-S-162eP}, PIK3CB (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta) [NCBI Gene 5291] {aka P110BETA, PI3K, PI3KBETA, PIK3C1}, CSNK2A2 (casein kinase 2 alpha 2) [NCBI Gene 1459] {aka CK2A2, CK2alpha', CSNK2A1}, PIK3CA (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) [NCBI Gene 5290] {aka CCM4, CLAPO, CLOVE, CWS5, HMH, MCAP}, ATG5 (autophagy related 5) [NCBI Gene 9474] {aka APG5, APG5-LIKE, APG5L, ASP, SCAR25, hAPG5}, GPX4 (glutathione peroxidase 4) [NCBI Gene 2879] {aka GPx-4, GSHPx-4, MCSP, PHGPx, SMDS, snGPx}, HIF1A (hypoxia inducible factor 1 subunit alpha) [NCBI Gene 3091] {aka HIF-1-alpha, HIF-1A, HIF-1alpha, HIF1, HIF1-ALPHA, MOP1}, MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}, Gpx4 (glutathione peroxidase 4) [NCBI Gene 625249] {aka GPx-4, GSHPx-4, PHGPx, mtPHGPx, snGPx}, Hif1a (hypoxia inducible factor 1, alpha subunit) [NCBI Gene 15251] {aka HIF-1-alpha, HIF1-alpha, HIF1alpha, MOP1, bHLHe78}, Pik3ca (phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha) [NCBI Gene 18706] {aka 6330412C24Rik, caPI3K, p110, p110alpha}
- **Diseases:** autoimmune disorders (MESH:D001327), obesity (MESH:D009765), MI (MESH:D007248), osteoarthritis (MESH:D010003), reproductive (MESH:D060737), varicocele (MESH:D014646), testicular injury (MESH:D013733), testicular and prostate cancers (MESH:D011471), hyperglycemia (MESH:D006943), trauma (MESH:D014947), inflammation (MESH:D007249), mitochondrial dysfunction (MESH:D028361), diabetic (MESH:D003920), cancer (MESH:D009369), Alzheimer's disease (MESH:D000544), Azoospermia (MESH:D053713), defects in spermatogenesis (MESH:C536875), PCD (MESH:D003643), mitotic catastrophe (MESH:D002388), infertility (MESH:D007246), spermatogenic failure (MESH:C562903), cardiovascular diseases (MESH:D002318), genital infections (MESH:D007239)
- **Chemicals:** BPA (MESH:C006780), SDS (MESH:D012967), gentamicin (MESH:D005839), copper (MESH:D003300), EdU (MESH:C022811), resveratrol (MESH:D000077185), PFOA (MESH:C023036), BaP (MESH:D001564), furans (MESH:D005663), quercetin (MESH:D011794), ginsenoside Rg3 (MESH:C097367), Triton X-100 (MESH:D017830), CO2 (MESH:D002245), LPS (MESH:D008070), PFA (MESH:C003043), TAK-242 (MESH:C507035), lipid (MESH:D008055), PVDF (MESH:C024865), PFOS (MESH:C076994), cadmium (MESH:D002104), BPB (MESH:C492482), ROS (MESH:D017382), baicalein (MESH:C006680), glucose (MESH:D005947), melatonin (MESH:D008550), curcumin (MESH:D003474), cisplatin (MESH:D002945), BPS (MESH:C543008), Alexa Fluor  594 (-), DMP (MESH:C024629)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** L2880 — Homo sapiens (Human), Turner syndrome, Transformed cell line (CVCL_9L42), GC-1 — Homo sapiens (Human), Transformed cell line (CVCL_6632), Im1spg — Homo sapiens (Human), Melanoma, Cancer cell line (CVCL_3980), GC-1 spg (ts — Mus musculus (Mouse), Transformed cell line (CVCL_8872)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12920511/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12920511/full.md

## References

43 references — full list in the complete paper: https://tomesphere.com/paper/PMC12920511/full.md

---
Source: https://tomesphere.com/paper/PMC12920511